1
|
Silva LP, Portela RW, Machado MC, Canuto GAB, Costa-Neto JM, de Carvalho VDMP, de Sá HC, Damasceno KA, de Souza VRC, Coelho CS, Estrela-Lima A. Ozone Therapy in the Integrated Treatment of Female Dogs with Mammary Cancer: Oxidative Profile and Quality of Life. Antioxidants (Basel) 2024; 13:673. [PMID: 38929112 PMCID: PMC11200475 DOI: 10.3390/antiox13060673] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2024] [Revised: 05/28/2024] [Accepted: 05/28/2024] [Indexed: 06/28/2024] Open
Abstract
Considering the high frequency of malignant breast tumors, there is a growing search for new therapeutic strategies that control neoplastic growth and dissemination, combined with fewer adverse reactions. Therefore, this study evaluated the effects of ozone therapy in female dogs with mammary cancer undergoing chemotherapy treatment. Twenty-five canines diagnosed with malignant mammary neoplasia were divided into two groups: one treated with carboplatin alone (n = 11) and the other with carboplatin associated with ozone therapy (n = 14). Clinical and laboratory evaluations, mastectomy, analysis of the oxidative profile based on total antioxidant capacity (TAC) and serum concentrations of malondialdehyde (MDA), survival rate, and quality of life were performed. Animals in the ozone therapy group had higher concentrations of red blood cells and platelets, significantly improving the survival rate and quality of life. Furthermore, adverse reactions were less intense and frequent in this group, which was associated with an increase in TAC and a reduction in MDA. These results indicate that the combination of carboplatin and ozone therapy represents a promising complementary treatment for female dogs with mammary cancer, as it was associated with fewer adverse reactions and a better oxidative profile.
Collapse
Affiliation(s)
- Laís Pereira Silva
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
| | - Ricardo Wagner Portela
- Laboratory of Immunology and Molecular Biology (LABIMUNO), Institute of Health Sciences, Federal University of Bahia, Salvador 40110-100, Brazil
| | - Marília Carneiro Machado
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
- Center for Agricultural, Environmental and Biological Sciences, Federal University of Reconcavo of Bahia, Cruz das Almas 44380-000, Brazil
| | - Gisele André Baptista Canuto
- Department of Analytical Chemistry, Institute of Chemistry, Federal University of Bahia, Salvador 40170-110, Brazil; (G.A.B.C.); (H.C.d.S.)
| | - João Moreira Costa-Neto
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
- Department of Anatomy, Pathology and Veterinary Clinics, Federal University of Bahia, Salvador 40170-110, Brazil
| | - Vitor de Moraes Pina de Carvalho
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
| | - Hanna Carvalho de Sá
- Department of Analytical Chemistry, Institute of Chemistry, Federal University of Bahia, Salvador 40170-110, Brazil; (G.A.B.C.); (H.C.d.S.)
| | - Karine Araújo Damasceno
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
- Experimental Pathology Laboratory (LAPEX), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (FIOCRUZ), Salvador 40296-710, Brazil
| | | | - Clarisse Simões Coelho
- Faculty of Veterinary Medicine, Lusofona University, 1749-024 Lisbon, Portugal; (V.R.C.d.S.); (C.S.C.)
- Veterinary and Animal Research Centre (CECAV), Faculty of Veterinary Medicine, Lusofona University, 1749-024 Lisbon, Portugal
- Mediterranean Institute for Agriculture, Environment and Development, Universidade de Évora, 7004-516 Évora, Portugal
| | - Alessandra Estrela-Lima
- Research Center on Mammary Oncology (NPqOM), Federal University of Bahia, Salvador 40170-110, Brazil; (L.P.S.); (M.C.M.); (J.M.C.-N.); (V.d.M.P.d.C.); (K.A.D.)
- Department of Anatomy, Pathology and Veterinary Clinics, Federal University of Bahia, Salvador 40170-110, Brazil
| |
Collapse
|
2
|
Milillo C, Aruffo E, Di Carlo P, Patruno A, Gatta M, Bruno A, Dovizio M, Marinelli L, Dimmito MP, Di Giacomo V, Paolini C, Pesce M, Ballerini P. Polystyrene nanoplastics mediate oxidative stress, senescence, and apoptosis in a human alveolar epithelial cell line. Front Public Health 2024; 12:1385387. [PMID: 38799687 PMCID: PMC11116779 DOI: 10.3389/fpubh.2024.1385387] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2024] [Accepted: 04/23/2024] [Indexed: 05/29/2024] Open
Abstract
Background Nanoplastics, an emerging form of pollution, are easily consumed by organisms and pose a significant threat to biological functions due to their size, expansive surface area, and potent ability to penetrate biological systems. Recent findings indicate an increasing presence of airborne nanoplastics in atmospheric samples, such as polystyrene (PS), raising concerns about potential risks to the human respiratory system. Methods This study investigates the impact of 800 nm diameter-PS nanoparticles (PS-NPs) on A549, a human lung adenocarcinoma cell line, examining cell viability, redox balance, senescence, apoptosis, and internalization. We also analyzed the expression of hallmark genes of these processes. Results We demonstrated that PS-NPs of 800 nm in diameter significantly affected cell viability, inducing oxidative stress, cellular senescence, and apoptosis. PS-NPs also penetrated the cytoplasm of A549 cells. These nanoparticles triggered the transcription of genes comprised in the antioxidant network [SOD1 (protein name: superoxide dismutase 1, soluble), SOD2 (protein name: superoxide dismutase 2, mitochondrial), CAT (protein name: catalase), Gpx1 (protein name: glutathione peroxidase 1), and HMOX1 (protein name: heme oxygenase 1)], senescence-associated secretory phenotype [Cdkn1a (protein name: cyclin-dependent kinase inhibitor 1A), IL1A (protein name: interleukin 1 alpha), IL1B (protein name: interleukin 1 beta), IL6 (protein name: interleukin 6), and CXCL8 (protein name: C-X-C motif chemokine ligand 8)], and others involved in the apoptosis modulation [BAX (protein name: Bcl2 associated X, apoptosis regulator), CASP3 (protein name: caspase 3), and BCL2 (protein name: Bcl2, apoptosis regulator)]. Conclusion Collectively, this investigation underscores the importance of concentration (dose-dependent effect) and exposure duration as pivotal factors in assessing the toxic effects of PS-NPs on alveolar epithelial cells. Greater attention needs to be directed toward comprehending the risks of cancer development associated with air pollution and the ensuing environmental toxicological impacts on humans and other terrestrial mammals.
Collapse
Affiliation(s)
- Cristina Milillo
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Eleonora Aruffo
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Piero Di Carlo
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Psychological, Health and Territorial Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Antonia Patruno
- UdA-TechLab, Research Center, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Medicine and Aging Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Marco Gatta
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Annalisa Bruno
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Melania Dovizio
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Lisa Marinelli
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Marilisa Pia Dimmito
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Viviana Di Giacomo
- UdA-TechLab, Research Center, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Pharmacy, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Cecilia Paolini
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Neuroscience, Imaging and Clinical Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Mirko Pesce
- UdA-TechLab, Research Center, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Medicine and Aging Sciences, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| | - Patrizia Ballerini
- Center for Advanced Studies and Technology (CAST), “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
- Department of Innovative Technologies in Medicine & Dentistry, “G. d’Annunzio” University of Chieti-Pescara, Chieti, Italy
| |
Collapse
|
3
|
Li Y, Pu R. Ozone Therapy for Breast Cancer: An Integrative Literature Review. Integr Cancer Ther 2024; 23:15347354241226667. [PMID: 38258533 PMCID: PMC10807353 DOI: 10.1177/15347354241226667] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2023] [Revised: 12/04/2023] [Accepted: 01/02/2024] [Indexed: 01/24/2024] Open
Abstract
Breast cancer is the most prevalent form of cancer in women. Despite significant advances in conventional treatment, additional safer complementary treatment options are needed. Recently, ozone therapy has been considered as a type of medical adjunctive treatment that could inhibit cancer cell survival and reduce chemoresistance. However, only a few studies have been conducted on its use in breast cancer, and the optimal dosage and time of administration are unknown. Currently, preclinical studies suggest that ozone alone or in combination with chemotherapy is an effective method for inhibiting breast cancer cell growth. However, rather than investigating the effects of ozone as an antitumor therapy, current clinical trials have generally assessed its effect as an adjunctive therapy for reducing chemotherapy-induced side effects, increasing oxygen tension, normalizing blood flow, restoring blood lymphocytes more rapidly, and reducing fatigue symptoms. In this article, the use of ozone as a medical adjunctive treatment for breast cancer and its role in integrative therapy are summarized and discussed.
Collapse
Affiliation(s)
- Yanchu Li
- West China Hospital of Sichuan University, Chengdu, China
| | - Rong Pu
- Chengdu Fuxing Hospital, Chengdu, China
| |
Collapse
|